Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe short answer: you can inject Mounjaro on any day of the week, at any time of day, with or without food. What matters is that you do it on the same day each week, roughly 7 days apart, and stick to that pattern consistently. That rhythm is what the licensed prescribing schedule is built around, and it is what the SURMOUNT clinical programme — which studied tirzepatide across thousands of adults with obesity — was designed to reflect. Mounjaro (tirzepatide) is a prescription-only medicine; a GPhC-registered prescriber assesses whether it is clinically suitable for you before treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Tirzepatide's pharmacology is the starting point here. Its half-life of roughly five days means the medicine accumulates steadily over several weeks of once-weekly injections before reaching a stable level in your system. The SURMOUNT-1 trial, published in the New England Journal of Medicine, ran participants on a fixed weekly schedule (not a flexible one) and that structure is reflected in the licensed prescribing information. Consistency, not clock-precision, is what produces the conditions the trial measured.
In practice, this means the gap between injections should be as close to seven days as possible. The Mounjaro SmPC allows a small window either side if your schedule genuinely forces a shift, but treating every week as negotiable is not what the licensed regimen describes. Pick a day that suits your life and protect it.
You can read more about tirzepatide's mechanism and what the evidence shows on our Mounjaro overview page.
No published evidence suggests injecting in the morning performs differently from injecting in the evening. The NHS tirzepatide medicine page confirms that Mounjaro can be taken at any time of day and with or without food, which is one practical advantage over the oral semaglutide tablet, which requires a strict fasted window each morning.
What does matter is choosing a time you will actually remember. Many people anchor their injection to a routine they already have: a Sunday evening after dinner, a Monday morning before leaving for work. If you want to think through when to inject Mounjaro in more detail, the exact hour is far less important than the habit itself. One thing worth knowing is that side effects, particularly nausea, tend to be most noticeable in the hours immediately after an injection, especially early in treatment. Some people find injecting in the evening means any discomfort settles overnight.
If you are thinking about where to inject Mounjaro as well as when, the site you choose each week should rotate, abdomen, thigh and upper arm are all licensed options.
Mounjaro must be kept refrigerated at 2–8°C between uses. For many people, the pen lives in the fridge door (same shelf, same spot) which doubles as a practical reminder that injection day is coming. The Patient Information Leaflet sets out the exact room-temperature window if you need to travel with it; always check that document for the specific figures rather than relying on general advice online. Our Mounjaro storage guide covers what to do in common real-world situations, and for anything less routine, your prescriber is the right person to ask.
Because you are using a single pen over four weekly injections, keeping track of which dose you are on matters too. Each pen delivers four doses at the same strength, so running out mid-week can disrupt your schedule. Ordering your next pen with enough lead time is practical planning, not overcaution. If you want to understand the full injection process before you begin, our guide on where to inject tirzepatide covers the licensed sites and how to rotate them correctly, and the Mounjaro injection guide walks through technique step by step.
Life interrupts routines. If you need to move your injection day permanently (say, from Wednesday to Saturday) the SmPC allows a gradual shift over a couple of weeks rather than a sudden jump. For a one-off delay or a missed dose, the Patient Information Leaflet gives specific guidance based on how many days have passed since your scheduled injection. The rule of thumb from the licensed prescribing information is that if it is five or more days late, skip that dose and resume on your usual next injection day. Do not inject two doses close together to compensate.
Missed-dose decisions are exactly the kind of question our aftercare team is available to help with, seven days a week. Our prescribers review every treatment (not just the first consultation) so you always have a clinical point of contact, not just a helpline. If you are considering starting treatment and want to understand the full picture, checking your eligibility is the straightforward next step.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.